Drug Type Synthetic peptide |
Synonyms Cereport, Labradimil (INN/USAN), Lobradimil + [2] |
Target |
Mechanism B2 receptor agonists(Bradykinin B2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC49H75N15O12S |
InChIKeyIDXCXSCCZNCXCL-XMADEQCMSA-N |
CAS Registry159768-75-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Phase 3 | - | - | |
Brain Cancer | Phase 3 | - | - | |
Glioma | Phase 2 | US | - | - |
Glioma | Phase 2 | EU | - | - |
Brain Stem Glioma | Phase 1 | US | 01 Feb 2001 | |
HIV Infections | Phase 1 | US | 02 Nov 1999 | |
Meningitis, Cryptococcal | Phase 1 | US | 02 Nov 1999 | |
Medulloblastoma | Phase 1 | US | 01 Apr 1996 |